Johnson & Johnson Innovation
Latin America Challenge


Are you an early stage entrepreneurial or start-up company from Latin America with a game-changing, transformative healthcare innovation or technology? Do you want the opportunity to pitch to Johnson & Johnson experts and win exclusive benefits? Johnson & Johnson Innovation is launching the Latin America Challenge 2017!

J&J is the largest healthcare company in the world, with a focus on pharmaceutical therapies for cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuroscience, and oncology; medical devices for surgical oncology, obesity, osteoarthritis, osteoporosis, and cardiovascular illnesses; and consumer healthcare solutions for infants, skin and beauty, over the counter medications, oral health, wound healing and women’s health (with the trusted brands JOHNSON'S, NEUTROGENA, TYLENOL, LISTERINE, BAND-AID and CAREFREE).

We are looking for innovators with the best ideas, technologies, or solutions across all stages (prototype, pre-clinical, clinical, commercial) that are advancing healthcare discovery & development in any of these specific areas:

Personal Devices, Diagnostics or Digital Therapeutics
For everyday consumer´s health self-care and treatment, particularly in the areas of sleep, skin care, pain, mom&baby care, and oral health.

Active Naturals and Microbiome
Superior efficacy in novel ingredients for oral care, skin care, digestive health, feminine care, pain or allergy applications.

Outdoor Care
Protection against sun, pollution, dehydration, allergens, bugs and germs.

Oncology, Neuroscience and Infectious Diseases
Prevention, diagnostics and novel therapeutics solutions.

To that end, Johnson & Johnson Innovation is looking to award up to $25,000 in grants, potential for residency at a JLABS incubator & opportunities to engage with J&J experts to the individuals or teams who submit the best ideas, technologies, or solutions to advance healthcare.


1. Where do I apply?

2. What sectors are J&J looking for?
Consumer Healthcare and Pharmaceutical.

3.  What stage and locations are companies eligible to apply?
The challenge is open to any incorporated companies from Latin America.

4. Is it ok if some of the information I submit is confidential?
Do not submit confidential information. Only non-confidential information should be submitted.

5. What happens with IP?
As this is a no strings attached arrangement, the IP remains with the inventors.

6. When is the application deadline?
January 31st 2018.

7. When and where will the winners be announced?
March 18th 2018, at the OIW in São Paulo – Brazil.

8. What is being awarded and to how many companies?
Up to US$25,000 in grants, potential for residency at a JLABS incubator & opportunity to engage with J&J experts, to one team who submit the best idea, technology, or solution to advance healthcare.

9. What facilities will be available at JLABS? And for how many people?
Lab space and a workstation/office space for 2 people max. It is required to sign a License Agreement for JLABS before being granted access to the bench and workstation. Johnson & Johnson Innovation reserves the right to review and approve any finalist and may choose to refuse and/or revoke any such grant of access to JLABS, at any time, acting in its sole and absolute discretion.  More information at

10. Will J&J pay for living costs in the selected region and relocate family?

11. Do you help with immigration issues for working in US?  What visa needed?
Applicants need to do their own research or talk to their own legal counsel to ensure they abide by the rules in place governing acceptable activities in the United States for temporary business visitors. We also do not sponsor applicants as the facilities provided are simply a platform for them to use while they conduct their own acceptable business practices.

12. If selected, when is move-in?
To be negotiated.

100 Open Startups   |   Rules and Regulations   |     Facebook